IBO IMPACT BIOMEDICAL INC.: institutional ownership and insider trading
22 funds reported holding $2.17M of IMPACT BIOMEDICAL INC. in their latest 13F filings; in Q2 2026 funds net bought $51.5K, with 3 new positions and 0 funds selling out; over the last 12 months insiders bought $0 and sold $59.5K on the open market.
Famous investors holding IBO
- Ken Griffin (Citadel Advisors): $22.8K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $7.91K, 0.0% of the portfolio
Largest institutional holders of IBO
- GEODE CAPITAL MANAGEMENT, LLC — $546K
- VANGUARD GROUP INC — $412K
- VANGUARD CAPITAL MANAGEMENT LLC — $372K
- STATE STREET CORP (STT, STT-PG) — $280K
- VANGUARD FIDUCIARY TRUST CO — $271K
- BlackRock, Inc. (BLK) — $120K
- NORTHERN TRUST CORP (NTRS, NTRSO) — $108K
- CITADEL ADVISORS LLC — $22.8K
- Vanguard Global Advisers, LLC — $14.8K
- JANE STREET GROUP, LLC — $11.3K
Recent IBO insider trades
- Sep 24, 2026: Dss, Inc. sold 906 shares ($1.69K)
- Mar 27, 2026: Macko Todd D sold 45,000 shares ($25.3K)
- Mar 23, 2026: Grady Jason sold 50,000 shares ($32.5K)
- May 27, 2025: Dss, Inc. sold 161,000 shares ($88.1K)